Clincosm LogoSign in Get a demo

Acromegaly

Showing 26 - 50 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acromegaly Trial in Worldwide (Paltusotine)

Completed
  • Acromegaly
  • Los Angeles, California
  • +44 more
Jul 27, 2021

Acromegaly Trial in Worldwide (Paltusotine, Placebo)

Completed
  • Acromegaly
  • Los Angeles, California
  • +44 more
Jul 13, 2021

Bone MicroArchitecture in Acromegaly

Completed
  • Acromegaly
  • Osteoporosis Risk
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University
Jul 12, 2021

Treatment Patterns and Treatment Outcomes for Acromegaly

Recruiting
  • Acromegaly
    • New York, New York
      Neuroendocrine Unit at Columbia University Irving Medical Center
    Jul 12, 2021

    Patients With Associated Somatic Disorders

    Completed
    Has Results
    • Acromegaly
    • Non-interventional cross-sectional survey
    • Moscow, Russian Federation
    • +1 more
    May 7, 2021

    Micromegaly and Discrepancy Between Growth Hormone and IGF1 at

    Recruiting
    • Acromegaly
      • Montpellier, France
        Uhmontpellier
      Apr 22, 2021

      Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)

      Completed
      • Carcinoid Tumor
      • Acromegaly
      • Los Angeles, California
      • +16 more
      Dec 17, 2020

      Acromegaly - Before and After Treatment

      Unknown status
      • Acromegaly
      • +4 more
        • Aarhus, Denmark
          Aarhus University Hospital, Department of internal medicine and
        Dec 4, 2020

        The Treatment and Natural History of Acromegaly

        Completed
        • Acromegaly
        • Pituitary Neoplasm
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Nov 24, 2020

          Acromegaly Trial in Worldwide (octreotide capsules, Matching )

          Active, not recruiting
          Has Results
          • Acromegaly
          • octreotide capsules
          • Matching placebo
          • Los Angeles, California
          • +59 more
          Nov 4, 2020

          Acromegaly Trial in United States (Somatuline Autogel (lanreotide acetate), Home administration)

          Completed
          Has Results
          • Acromegaly
          • Somatuline Autogel (lanreotide acetate)
          • Home administration
          • La Mesa, California
          • +12 more
          Nov 4, 2020

          Acromegaly: Patient And Physician Perspectives

          Completed
          • Acromegaly
            • New Orleans, Louisiana
              Tulane School of Public Health and Tropical Medicine
            Oct 27, 2020

            Acromegaly, Growth Hormone Deficiency, Pituitary Disease Trial in Boston (Recombinant human growth hormone, Saline)

            Completed
            Has Results
            • Acromegaly
            • +2 more
            • Recombinant human growth hormone
            • Saline
            • Boston, Massachusetts
              Massachusetts General Hospital
            Aug 31, 2020

            Headache, Pituitary Tumor, Acromegaly Trial (Transcranial magnetic stimulation, Acetaminophen)

            Not yet recruiting
            • Headache
            • +2 more
            • (no location specified)
            Aug 25, 2020

            Acromegaly, Cardiomyopathies Trial in Shanghai (Empagliflozin)

            Recruiting
            • Acromegaly
            • Cardiomyopathies
            • Shanghai, Shanghai, China
              Huashan Hospital
            Aug 17, 2020

            Dynamic Hormone Diagnostics in Endocrine Disease

            Unknown status
            • Adrenal Insufficiency
            • +5 more
            • 27 hour subcutaneous fluid sampling
            • Athen, Greece
            • +3 more
            Aug 3, 2020

            Predict Lanreotide-induced Disease Activity Normalization in

            Withdrawn
            • Acromegaly
              • (no location specified)
              Jun 1, 2020

              Acromegaly Trial in France, Switzerland (Lanreotide (Autogel formulation))

              Completed
              • Acromegaly
              • Lanreotide (Autogel formulation)
              • Amiens, France
              • +16 more
              Mar 30, 2020

              SAGIT for Classification of Acromegaly in Clinical Practice

              Completed
              • Acromegaly
              • SAGIT
              • Los Angeles, California
              • +20 more
              Mar 30, 2020

              Seoul National University Pituitary Disease Cohort Study

              Recruiting
              • Pituitary Disease
              • +7 more
              • Dynamic hormone study and Magnetic resonance imaging
              • Seoul, Korea, Republic of
                Seoul National University Hospital
              Mar 17, 2020

              Acromegaly, Olfactory Disorder Trial in Istanbul (OB volume, CCCRC test)

              Completed
              • Acromegaly
              • Olfactory Disorder
              • OB volume
              • CCCRC test
              • Istanbul, Fatih, Turkey
                Bezmialem Vakif University
              Mar 13, 2020

              Acromegaly Trial in Worldwide (Pasireotide LAR)

              Completed
              Has Results
              • Acromegaly
              • Pasireotide LAR
              • Caba, Buenos Aires, Argentina
              • +49 more
              Dec 6, 2019

              Acromegaly Trial in Munich (lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval)

              Completed
              • Acromegaly
              • lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval
              • Munich, Germany
                Klinikum Innenstadt
              Nov 21, 2019

              Acromegaly Trial in Worldwide (BIM 23A760)

              Terminated
              Has Results
              • Acromegaly
              • BIM 23A760
              • Los Angeles, California
              • +22 more
              Nov 21, 2019

              Acromegaly Trial in Groningen (ONO-5788, [14C]-ONO-5788)

              Completed
              • Acromegaly
              • Groningen, NZ, Netherlands
                PRA-EDS
              Nov 6, 2019